BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Morgan Stanley upgrades Biocon to overweight
Morgan Stanley upgrades Biocon to overweight with a target price of Rs 622 per share. The brokerage says 2016 could be a turning point for Biocon. Four potential product filings likely each in US and European Union. Emerging market monetisation is underway. Bull case target for the stock is Rs 759.